Research across Schizophrenia
Related studies from across the Schizophrenia family.
Affective dysregulation and self-blame predict voices and delusions in schizophrenia-spectrum disorders with PTSD
Mapping the connections between trauma symptoms and voices in schizophrenia
This randomized controlled trial involved 305 participants with schizophrenia-spectrum disorder, distressing symptoms, and comorbid PTSD. Ne…
New research looks at how feelings of self-blame and mood swings impact people living with schizophrenia and PTSD.
rTMS shows no significant benefit over sham for treatment-resistant schizophrenia
Trial shows no clear benefit from magnetic brain stimulation
This meta-analysis of randomized trials found that repetitive transcranial magnetic stimulation (rTMS) did not significantly improve overall…
New data suggests that repetitive transcranial magnetic stimulation may not improve symptoms for people with treatment-resistant schizophren…
Dynamic gratings serve as tools for diagnosis and treatment evaluation in neuro-ophthalmic conditions
Dynamic gratings help doctors understand and treat eye conditions
This narrative review explores the use of dynamic gratings, such as phase-alternating oscillation and rapid serial visual presentation, to e…
Moving patterns on a screen, called dynamic gratings, offer new ways to study and treat vision issues like glaucoma and diabetic retinopathy…
Speech latency ratios as a vocal biomarker identify patients with improved treatment outcomes in schizophrenia
Vocal biomarker may boost schizophrenia trial results
This Phase 3 randomized controlled trial of 406 participants with acute psychosis evaluated brilaroxazine and speech latency ratios as a voc…
A voice-based test could help identify patients most likely to respond to a new schizophrenia drug, improving trial outcomes.
Transcranial focused ultrasound shows promise for schizophrenia but evidence remains preliminary
Focused Ultrasound Shows Potential to Treat Schizophrenia Symptoms
This narrative review examines transcranial focused ultrasound stimulation (tFUS) for schizophrenia. In rodent models, tFUS reversed cogniti…
New research explores how focused ultrasound may improve cognitive function and manage symptoms in people living with schizophrenia.
Repetitive transcranial magnetic stimulation addresses various mental disorders including depression, bipolar disorder, and schizophrenia
Repetitive Transcranial Magnetic Stimulation Shows Potential for Mental Disorders
This narrative review synthesizes the therapeutic effects of repetitive transcranial magnetic stimulation (rTMS) for conditions such as depr…
New research reviews how magnetic stimulation may help manage conditions like depression, bipolar disorder, and autism by affecting brain pl…
11 risk factors identified for predicting relapse in patients with schizophrenia
New risk factors identified to predict schizophrenia relapse
This meta-analysis of 159,973 participants identified 11 specific risk factors associated with relapse in patients with schizophrenia. A pre…
A large analysis identifies eleven specific risk factors that may help doctors predict and prevent relapses in patients with schizophrenia.
GFAP levels significantly elevated in schizophrenia patients versus controls, meta-analysis finds
Higher protein levels in blood may signal brain damage
This meta-analysis of 854 participants found that serum and plasma glial fibrillary acidic protein (GFAP) levels are significantly higher in…
A specific protein called GFAP is found at higher levels in people with schizophrenia, potentially marking damage to brain cells.
N170 ERP components show early visual perceptual deficits in schizophrenia spectrum disorders
Brain signals show early visual processing issues in schizophrenia
This meta-analysis examines event-related potentials (ERP) during face processing in individuals with schizophrenia spectrum disorders (SSD)…
New research highlights specific brain activity changes during face processing that may help identify early signs of schizophrenia spectrum …
Berberine reduces weight, lipids in schizophrenia with metabolic syndrome: meta-analysis
Berberine may improve weight and cholesterol in schizophrenia patients
This meta-analysis of 3 RCTs (233 patients) found that adjunctive berberine significantly reduced body weight, BMI, waist circumference, tot…
Adding berberine to treatment could help people with schizophrenia manage weight, waist size, and cholesterol levels.
GLP-1R exposure shows no causal link to most mental disorders except eating disorders
GLP-1 Receptor Agonists Show Mixed Links to Mental Health
This meta-analysis investigated the causal associations between GLP-1 receptor agonists and various mental health outcomes including anxiety…
New research explores how GLP-1 receptor agonists relate to conditions like anxiety and depression, finding no clear genetic link to most di…
Resting-state qEEG identifies distinct neurophysiological signatures in chronic schizophrenia compared to first-episode psychosis
Brain wave patterns help distinguish schizophrenia from early psychosis
This systematic review of 19 studies evaluates resting-state quantitative electroencephalography (qEEG) as a biomarker for schizophrenia and…
New research shows that specific brain wave changes can tell the difference between chronic schizophrenia and first-episode psychosis.